Idorsia Ltd (OTCMKTS:IDRSF) Short Interest Update

Idorsia Ltd (OTCMKTS:IDRSF) was the recipient of a large decrease in short interest in March. As of March 31st, there was short interest totalling 8,420,100 shares, a decrease of 7.6% from the March 15th total of 9,112,700 shares. Based on an average daily trading volume, of 6,500 shares, the short-interest ratio is presently 1,295.4 days.

Idorsia Price Performance

Shares of IDRSF remained flat at $2.03 during trading hours on Tuesday. The company had a trading volume of 5,000 shares, compared to its average volume of 3,788. Idorsia has a 12 month low of $1.40 and a 12 month high of $10.70. The stock’s 50 day moving average is $2.02 and its 200-day moving average is $2.17.

Idorsia Company Profile

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.